Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × Urologic Neoplasms × Clear all

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Urologic Neoplasms

NCT03204266 2022-08-24

Oral Supplementation to Enhance Recovery Pilot Study

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms, Urologic Neoplasms